Note: Claims are shown in the official language in which they were submitted.
THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:
1. A preparation for defoliating ox regulating the growth
of plants, which comprises a defoliating or growth-regulating
compound selected from 1,2,3-thiadiazol-5-yl-urea deriva-
tives and 1,2,3-thiadiazolin-2-ide derivatives, in admix-
ture or conjunction with an alkaline reacting substance,
the ratio by weight of the defoliating or growth-regulating
compound to the alkaline reacting substance being within the range
of from 1:0.5 to 1:1000.
2. A preparation as claimed in claim 1, wherein the de-
foliating or growth-regulating compound is a 1,2,3-thiadia-
zol-5-yl-urea derivative of the general formula I
<IMG> (I)
in which R1 represents a hydrogen atom or a C1-C5-alkyl group,
R2 represent a C1-C5-alkyl group, a C5-C8-cycloalkyl group,
a phenyl, halogenated phenyl, C1-C4-alkylphenyl, C1-C4-
alkoxyphenyl, nitrophenyl or trifluoromethylphenyl group, an
unsubstituted pyridyl or pyrimidyl group or a pyridyl or pyr-
imidyl group substituted by one or more substituents selected
from C1-C4-alkyl groups, C1-C4-alkoxy groups, halogen atoms,
nitro groups and trifluoromethyl groups, or R1 and R2 together
with the adjacent nitrogen atom represents a morpholino,
piperidino or pyrrolidino group, R3 represents a hydrogen
atom or a C1-C5-alkyl group, and X represents an oxygen or
sulphur atom.
3. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is selected from the group
consisting of 1-Phenyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-Phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-Cyclohexyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3,4-Dichlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-Methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1,1-Dimethyl-3-(1,2,3-thiadiazol-5-yl)-urea
1,1-Dimethyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-Methyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-urea
1-Phenyl-3-(1,2,3-thiadiazol-5-yl)-thiourea
1-(4-Chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-thiourea
1-(2-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Chloro-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(2-Pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea and
1-(6-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
4. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-3-(1,2,3-thia-
diazol-5-yl)-urea.
5. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-1-methyl-3-
(1,2,3-thiadiazol-5-yl)-urea.
6. A preparation as claimed in claim 2, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-(2-pyridyl)-3-(1,2,3-
thiadiazol-5-yl)-urea.
7. A preparation as claimed in claim 1, wherein the de-
foliating or growth-regulating compound is a 1,2,3-thiadia-
zolin-2-ide derivative of the general formula II
26
<IMG>
(II)
in which R1 represents a hydrogen atom or a C1-C5-alkyl group,
R2 represents a hydrogen atom, a C1-C5-alkyl group, a C5-C8-
cycloalkyl group, a phenyl, halogenated phenyl, C1-C4-alkyl-
phenyl, C1-C4-alkoxyphenyl, nitrophenyl or trifluoromethyl-
phenyl group, an unsubstituted pyridyl or pyrimidyl group or
a pyridiyl or pyrimidyl group substituted by one or more sub-
stituents selected from C1-C4-alkyl groups, C1-C4-alkoxy
groups, halogen atoms, nitro groups and trifluoromethyl
groups, or R1 and R2 together with the adjacent nitrogen
atom represent a morpholino, piperidino or pyrrolidino
group, B represents an alkali metal atom or a monovalent
equivalent of zinc, manganese, calcium, magnesium or barium,
and X represents an oxygen or sulphur atom.
8. A preparation as claimed in claim 7, wherein B repre-
sents a lithium, sodium or potassium atom.
9. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is selected from the group
consisting of:
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, sodium
salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, calcium
salt x8H2O
5-(Phenylcarbamoyliminol)-1,2,3-thiadiazolin-2-ide, potassium
salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, lithium
salt x4H2O
5-(Methylphenylcarbamoyliminol-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
27
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salk xH2O
5-(2 Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt x1.5 H2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH20
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(Phenylthiocarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, magnesium
salt x2H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, zinc salt
x3H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, manganese
salt x3H20
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, barium
salt x3H20.
10. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the calcium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
11. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the magnesium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
12. A preparation as claimed in claim 7, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the manganese salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
13. A preparation as claimed in claim 13, wherein the
alkaline reacting substance is an alkali hydroxide, an amine,
a carbonate, a phosphate or an alkali salt of a monocarboxylic
acid.
14. A preparation as claimed in claim 13, wherein the alkali
hydroxide is sodium or potassium hydroxide.
15. A preparation as claimed in claim 13, wherein the amine
28
is triethylamine, diethanolamine, triethanolamine, triiso-
propanolamine or hexamethylenetetramine.
16. A preparation as claimed in claim 13, wherein the car-
bonate is sodium carbonate, potassium carbonate or ammonium
carbonate.
17. A preparation as claimed in claim 13, wherein the phos-
phate is trisodium phosphate, tripotassium phosphate, tetra-
sodium pyrophosphate or tetrapotassium pyrophosphate.
18. A preparation as claimed in claim 13, wherein the alkali
salt of a monocarboxylic acid is sodium oleate.
19. A preparation as claimed in claim 1, which comprises
1-phenyl-3-(1,2,3-thiadiazol-5-yl)-urea as the defoliating
or growth-regulating compound in admixture with potassium
hydroxide, potassium carbonate, ammonium carbonate, tetra-
potassium pyrophosphate, triethylamine, triethanolamine or
sodium oleate. as the alkaline reacting substance.
20. A preparation as claimed in claim 1, which comprises
1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea as the defol-
iating or growth-regulating compound in admixture with pot
assium carbonate as the alkaline reacting substance.
21. A preparation as claimed in claim 1, which comprises
the calcium salt of 5-(phenylcarbamoylimino)-1,2,3-thiadia-
zolin-2-ide as the defoliating or growth-regulating compound
in admixture with potassium carbonate as the alkaline reacting
substance
22. A preaparation as claimed in claim 1 having a pH-value
greater than 8.
23. A preparation as claimed in claim 22, having a pH-value
within the range of from 9.5 to 11.5.
24. A preparation as claimed in claim 1, which also contains
at least one of a liquid carrier and a solid carrier.
29
25. A preparation as claimed in claim 24, containing 5 to
95% by weight of the defoliating or growth-regulating
compound and the alkaline reacting substance and 95 to 5%
by weight of at least one of the liquid and solid carriers.
26. A preparation as claimed in claim 1, which also contains
a surface-active agent.
27. A preparation as claimed in claim 26, containing the
surface-active agent in an amount of up to 30% by weight.
28. A preparation as claimed in claim 1, 2 or 3, which also
contains one or more active substances selected from defol-
iating agents, plant-protecting agents and pesticides other
than 1,2,3-thiadiazol-5-yl-urea derivatives and 1,2,3-
thiadiazolin-2-ide derivatives.
29. A preparation as claimed in claim 1,2 or 3, which is in
the form of a powder, a strewable preparation, a solution,
an emulsion or a suspension.
30. A preparation selected from the group comprising of:
a) 95% by weight of mixture
4% by weight of kaolin
1% by weight of surface-active agents based on the
sodium salt of N-methyl-N-oleyl-taurine
and the calcium salt of lignin sulphon-
ic acid
b) 80% by weight of mixture
10% by weight of calcium salt of lignin sulphonic acid
3% by weight of ammonium salt of the monosulphuric
acid ester of tetraethylene glycol
nonyl phenyl ether
7% by weight of colloidal silicic acid
c) 20% by weight of mixture
70% by weight of tonsil
8% by weight of cellulose pitch
2% by weight of wetting agent based on a fatty acid
condensation product
and
d) 5% by weight of mixture
80% by weight of tonsil
10% by weight of cellulose pitch
5% by weight of wetting agent based on a fatty acid
condensation product,
31
said mixture being the mixture of a defoliating or growth-
regulating compound selected from 1,2,3-thiadiazol-5-vl-urea
derivatives and 1,2,3-thiadiazolin-2-ide derivatives, with an alkaline
reacting substance, the ratio by weight of the defoliating or growth-
regulating compound to the alkaline reacting substance being within
the range of from 1:0.5 to 1:1000.
31. A method of defoliating or regulating the
growth of a living plant at the stage of having at least 5
foliage leaves, wherein the living plant is treated with a
mixture comprising (i) a defoliating or growth regulating
compound selected from 1,2,3-thiadiazol-5-yl-urea derivatives
and 1,2,3-thiadiazolin-2-ide derivatives and (ii) an alkaline
reacting substance, the ratio by weight of the defoliating or
growth-regulating compound to the alkaline reacting substance
by within the range of from 1:0.5 to 1:1000.
32. A method as claimed in claim 31, wherein the
defoliating or growth-regulating compound is a 1,2,3-thiadia-
zol-5-yl-urea derivative of the general formula I given in
claim 2, in which R1, R2, R3 and X have the meanings given
in claim 2.
33. A method as claimed in claim 32, wherein the
1,2,3-thiadiazol-5-yl-urea derivative is selected from the
group consisting of: 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-
urea; 1-phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea;
1-(4-chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-cyclo-
hexyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1-(3-chlorophenyl)-3-
(1,2,3-thiadiazol-5-yl)-urea; 1-(4-methylphenyl)-3-(1,2,3-
thiadiazol-5-yl)-urea; 1-(3-methylphenyl)-3-(1,2,3-thiadiazol-
5-yl)-urea; 1-(3,4-dichlorophenyl)-3-(1,2,3-thiadiazol-5-
yl)-urea; 1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1,1-
dimethyl-3-(1, 2, 3-thiadiazol-5-yl)-urea; 1,1-dimethyl-3-methyl-
(1,2,3-thiadiazol-5-yl)-urea; 1-methyl-3-methyl-3-(1,2,3-thia-
32
diazol-5-yl)-urea; 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-thiourea;
1-(4-chlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-thiourea;
1-(2-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Chloro-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(2-Pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea and
1-(6-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
34. A method as claimed in claim 32, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-3-(1,2,3-thia-
diazol-5-yl)-urea.
35. A method as claimed in claim 32, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-phenyl-1-methyl-3-
(1,2,3-thiadiazol-5-yl)-urea.
36. A method as claimed in claim 32, wherein the 1,2,3-
thiadiazol-5-yl-urea derivative is 1-(2-pyridyl)-3-(1,2,3-
thiadiazol-5-yl)-urea.
37. A method as claimed in claim 32, wherein the defoliating
or growth-regulating compound is a 1,2,3-thiadiazolin-2-ide
derivative of the general formula II given in claim 7, in
which R1, R2, B and X have the meanings given in claim 7.
38. A method as claimed in clalm 37, wherein B represents
a lithium, sodium or potassium atom.
39. A method as claimed in claim 37, wherein the 1,2,3-
thiadiazolin-2-ide derivative is selected for the group
consisting of:
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, sodium
salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, calcium
salt x8H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, potassium
salt xH2O
34
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, lithium
salt x4H2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH20
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(Methylphenylcarbamoylmino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(2-Pyridylcarbamoylimino )-1,2,3-thiadiazolin-2-ide,
sodium salt x1.5 H2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(Phenylthiocarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, magnesium
salt x2H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, zinc salt
x3H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, manganese
salt x3H2O and
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, barium
salt x3H2O.
40. A method as claimed in claim 37, wherein the 1,2,3-
thiadiazolin-2-ide, derivative is the calcium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
41. A method as claimed in claim 37, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the magnesium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
42. A method as claimed in cl.aim 37, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the manganese salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
43. A method as claimed in claim 31, wherein the alkaline
reacting substance is an alkali hydroxide, an amine, a
carbonate, a phosphate or an alkali salt of a monocarboxylic
acid.
44. A method as claimed in claim 43, wherein the alkali
hydroxide is sodium or potassium hydroxide
45. A method as claimed in cliam 43, wherein the amine
is triethylamine, diethanolamine, triethanolamine, triiso-
propanolamine or hexamethylenetetramine.
46. A method as claimed in claim 43, wherein the carbonate
is sodium carbonate, potassium carbonate or ammonium carbon-
ate.
47. A method as claimed in claim 43, wherein the phosphate
is trisodium phosphate, tripotassium phosphate, tetrasodium
pyrophosphate or tetrapotassium pyrophosphate.
48. A method as claimed in claim 43, wherein the alkali
salt of a monocarboxylic acid is sodium oleate.
49. A method as claimed in claim 31, wherein the mixture
is a mixture comprising 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-
urea and potassium hydroxide, potassium carbonate, ammonium
carbonate, tetrapotassium pyrophosphate, triethylamine,
triethanolamine or sodium oleate.
50. A method as claimed in claim 31, wherein the mixture is
a mixture comprising 1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-
yl)-urea and potassium carbonate.
51. A method as claimed in claim 31, wherein the mixture
is a mixture comprising the calcium salt of 5-(phenylcarba-
moylimino)-1,2,3-thiadiazolin-2-ide and potassium carbonate.
52. A method as claimed in claim 31, wherein the pH-value
of the mixture is greater then 8.
53. A method as claimed in claim 52, wherein the pH-value
of the mixture is within the range of from 9.5 to 11.5.
54. A method as claimed in claim 31, wherein the mixture
also contains at least one of a liquid carrier and a solid
carrier.
36
55. A method as claimed in claim 54, wherein the mixture
contains 5 to 95% by weight of the defoliating or growth-
regulating compound and the alkaline reacting substance
and 95 to 5% being of at least one of the liquid and solid
carriers.
56. A method as claimed in claim 31, wherein the mixture
also contains a surface-active agent.
57. A method as claimed in claim 56, wherein the mixture
contains up to 30% by weight of the surface-active agent.
58. A method as claimed in claim 31, 32, or 33, wherein the
mixture also contains one or more active substances selected
from defoliating agents, plant-protecting agents and pestici-
des other than 1,2,3-thiadiazol-5-yl-urea derivatives and
1,2,3-thiadiazolin-2-ide derivatives.
59. A method as claimed in claim 31, 32 or 33, wherein the
mixture is in the form of a powder, a strewable preparation,
a solution, an emulsion or a suspension.
60. A method as claimed in claim 31, wherein the mixture
is selected from the group consisting of:
a) 95% by weight of mixture
4% by weight of kaolin
1% by weight of surface-active agents based on the
sodium salt of N-methyl-N-oleyl-taurine
and the calcium salt of lignin sulphon-
ic acid
b) 80% by weight ofmixture
10% by weight of calcium salt of lignin sulphonic acid
3% by weight of ammonium salt of the monosulphuric
acid ester of tetraethylene glycol
nonyl phenyl ether
7% by weight of colloidal silicic acid
c) 20% by weight of mixture
70% by weight of tonsil
8% by weight of cellulose pitch
2% by weight of wetting agent based on a fatty acid
37
condensaton product
and
d) 5% by weight of mixture
80% by weight of tonsil
10% by weight of cellulose pitch
5% by weight of wetting agent based on a fatty acid
condensation product
38
said mixture being the mixture of a defoliating or growth-
regulating compound selected from 1,2,3-thiadiazol-5-yl-urea
derivatives and 1,2,3-thiadiazolin-2-ide derivatives, with
an alkaline reacting substance, the ratio by weight of the
defoliating or growth-regulating compound to the alkaline
reacting substance being within the range of from 1:0.5 to
1:1000.
61. A method of defoliating or regulating the growth
of plants, at the stage of having at least 5 foliage leaves
in a crop area, wherein the crop area is treated with a mixture
comprising (i) a defoliating or growth-regulating compound
selected from 1,2,3-thiadiazol-5-yl-urea derivatives and 1,2,3-
thiadiazolin-2-ide derivatives and (ii) an alkaline reacting
substance, the ratio by weight of the defoliating growth-
regulating compound to the alkaline reacting substance being
within the range of from 1:0.5 to 1:1000.
62. A method as claimed in claim 61, wherein the
defoliating or growth-regulating compound is a 1,2,3-thia-
diazol-5-yl-urea derivative of the general formula I given
in claim 2, in which R1, R2, R3 and X have the meanings given
in claim 2.
63. A method as claimed in claim 62, wherein the
1,2,3-thiadiazol-5-yl-urea derivative is selected from the
group consisting of: 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-urea;
1-phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1-(4-chloro-
phenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-cyclohexyl-3-(1,2,3-
thiadiazol-5-yl)-urea; 1-(3-chlorophenyl)-3-(1,2,3-thiadiazol-
5-yl)-urea; 1-(4-methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea;
1-(3-methylphenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-(3,4-
dichlorophenyl)-3-(1,2,3-thiadiazol-5-yl)-urea; 1-methyl-3-
(1,2,3-thiadiazol-5-yl)-urea; 1,1-dimethyl-3-(1,2,3-thiadiazol-
5-yl)-urea; 1,1-dimethyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-
urea; 1-methyl-3-methyl-3-(1,2,3-thiadiazol-5-yl)-urea; 1-
phenyl-3-(1,2,3-thiadiazol-5-yl)-thiourea;
39
1-(4-Chlorophenyl)-3-(1,2,3 thiadiazil-5-yl)-thiourea
1-(2-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Chloro-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Methyl-2-pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(4-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(2-Pyrimidyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(3-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea
1-(5-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea and
1-(6-Methyl-2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
64. A method as claimed in claim 62, wherein the 1,2,3-thiadiazol-
5-yl-urea derivative is 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-urea.
65. A method as claimed in claim 62, wherein the 1,2,3-thiadiazol-
5-yl-urea derivative is 1-phenyl-1-methyl-3-(1,2,3-thiadiazol-5-yl)-
urea.
66. A method as claimed in claim 62, wherein the 1,2,3-thiadiazol-5-
yl-urea derivative is 1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-urea.
67. A method as claimed in claim 61, wherein the defoliating or grow-
th-regulating ccmpound is a 1,2,3-thiadiazolin-2-ide derivative of the
general formula II given in claim 7, in which R1, R2, B and X have the
meanings given in claim 7.
68. A method as claimed in claim 67, wherein B represents a lithium,
sodium or potassium atom.
69. A method as claimed in claim 67, wherein the 1,2,3-thiadiazolin-
2-ide derivative selected from the group consisting of:
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, calcium salt x8H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, potassium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, lithium salt x4H2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadaizolin-2-ide,
sodium salt xH2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(Methylphenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt x1.5 H2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
potassium salt xH2O
5-(2-Pyridylcarbamoylimino)-1,2,3-thiadiazolin-2-ide,
lithium salt xH2O
5-(Phenylthiocarbamoylimino)-1,2,3-thiadiazolin-2-ide,
sodium salt xH2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, magnesium
salt x2H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, zinc
salt x3H2O
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, manganese
salt x3H2O and
5-(Phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide, barium
salt x3H2O.
70. A method as claimed in claim 67, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the calcium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
71. A method as claimed in claim 67, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the magnesium salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
72. A method as claimed in claim 67, wherein the 1,2,3-
thiadiazolin-2-ide derivative is the manganese salt of 5-
(phenylcarbamoylimino)-1,2,3-thiadiazolin-2-ide.
73. A method as claimed in claim 61, wherein the alkaline
reacting substance is an alkali hydroxide, an amine, a car
bonate, a phosphate or an alkali salt of a monocarboxylic
acid.
41
74. A method as claimed in claim 73, wherein the alkali
hydroxide is sodium or potassium hydroxide.
75. A method as claimed in claim 73, wherein the amine
is triethylamine, diethanolamine, triethanolamine, triiso-
propanolamine or hexamethylenetetramine.
76. A method as claimed in claim 73, wherein the carbonate
is sodium carbonate, potassium carbonate or ammonium car-
bonate.
77. A method as claimed in claim 73, wherein the phosphate
is trisodium phosphate, tripotassium phosphate, tetrasodium
pyrophosphate or tetrapotassium pyrophosphate.
78. A method as claimed in claim 73, wherein the alkali
salt of a monocarboxylic acid is sodium oleate.
79. A method as claimed in claim 61, wherein the mixture is
a mixture comprising 1-phenyl-3-(1,2,3-thiadiazol-5-yl)-
urea and potassium hydroxide, potassium carbonate, ammonium
carbonate, tetrapotassium pyrophosphate, triethylamine, tri-
ethanolamine or sodium oleate.
80. A method as claimed in claim 61, wherein the mixture is
a mixture comprising 1-(2-pyridyl)-3-(1,2,3-thiadiazol-5-yl)-
urea and potassium carbonate.
81. A method as claimed in claim 61, wherein the mixture
is a mixture comprising the calcium salt of 5-(phenylcarba-
moylimino)-1,2,3-thiadiazolin-2-ide and potassium carbonate.
82. A method as claimed in claim 61, wherein the pH-value of
the mixture is greater than 8.
83. A method as claimed in claim 82, wherein the pH-value
of the mixture is within the range of from 9.5 to 11.5.
84. A method as claimed in claim 61, wherein the mixture
also contains at least one of a liquid carrier and a solid
carrier.
85. A method as claimed in claim 84, wherein the mixture
contains 5 to 95% by weight of the defoliating or growth-
42
regulating compound and the alkaline reacting substance and
95 to 5% by weight of at least one of the liquid and solid
carriers.
86. A method as claimed in claim 61, wherein the mixture
also contains a surface-active agent.
87. A method as claimed in claim 86, wherein the mixture
contains up to 30% by weight of the surface-active agent.
88. A method as claimed in claim 61, 62, or 63, wherein the
mixture also contains one or more active substances selected
from defoliating agents, plant-protecting agents and pestici-
des other than 1,2,3-thiadiazol-5-yl-urea derivatives and
1,2,3-thiadiazolin-2-ide derivatives.
89. A method as claimed in claim 61, 62, or 63, wherein the
mixture is in the form of a powder, a strewable preparation,
a solution, an emulsion or a suspension.
90. A method as claimed in claim 61, wherein the mixture is
selected from the group consisting of:
a) 95% by weight of mixture
4% by weight of kaolin
1% by weight of surface-active agents based on the
sodium salt of N-methyl-N-oleyl-taurine
and the calcium salt of lignin sulphon-
ic acid
b) 80% by weight of mixture
10% by weight of calcium salt of lignin sulphonic acid
3% by weight of ammonium salt of the monosulphuric
acid ester of tetraethylene glycol
nonyl phenyl ether
7% by weight of colloidal silicic acid
c) 20% by weight of mixture
70% by weight of tonsil
8% by weight of cellulose pitch
2% by weight of wetting agent based on a fatty acid
condensation product
43
and
d) 5% by weight of mixture
80% by weight of tonsil
10% by weight of cellulose pitch
5% by weight of wetting agent based on a fatty acid
condensation product
said mixture being the mixture of a defoliating or growth-
regulating compound selected from 1,2,3-thiadiazol-5-yl-
urea derivatives and 1,2,3-thiadiazolin-2-ide derivatives,
with an alkaline reacting substance, the ratio by weight of
the defoliating or growth-regulating compound to the alkaline
reacting substance being within the range of from 1:0.5 to
1:1000.
91. A method as claimed in claim 61, wherein the
total amount of the defoliating or growth-regulating compound
and the alkaline reacting substance used for the treatment
is within the range of from 1 to 10,000 grams per hectare.
92. A method as claimed in claim 91, wherein the
total amount is within the range of from 10 to 1000 grams per
hectare.
93. A method as claimed in any one of claims 81,
82 or 83, wherein the crop area contains cotton plants.
44